Psoriatic Arthritis Recommendations - GRAPPA

5 are involved? Dactylitis NSAIDs DMARDs (MTX, LEF, SSZ ) or PDE4i Biologics (TNFi, IL12/23i) Corticosteroid Injections as indicated Switch biologic (TNFi, IL12/23i, IL17i ) or PDE4i Skin Topicals (keratolytics, steroids, vit D analogues, emollients, calcineurin i) Phototx or DMARDs (MTX, CyA, acitretin, fumaric acid esters) or PDE4i Biologics (TNFi, IL12/23i IL17i) or PDE4i Topicals as indicated Switch biologic (TNFi, IL12/23i, IL17i) or PDE4i Nails Biologics (TNFi, IL12/23i, IL17i) or PDE4i Topicals or Procedural or DMARDs (CyA, LEF, MTX, Acitretin) Switch biologic (TNFi, IL12/23i, IL17i) or PDE4i Treat periodically. Re-evaluate and modify therapy as required. NOTE: Grey, italic text identifies conditional recommendations where recommendations are based on abstract data only.

• Cover
• Key Points
• Overarching Principles
• Strength of Recommendations in GRADE
• GRAPPA Treatment Schema for Active PsA
• Summary of Recommendations by Domain
• Treatment Recommendations
• Comorbidities
• Abbreviations and Sources